What New Products and Models Are JPM Multinationals Focusing On in 2025?JPMDiscover the latest trends in the 2025 biopharma industry! From Johnson & Johnson's $14.6B acquisition to Eli Lilly's impressive revenue growth, major M&As, and cutting-edge therapies across oncology, neuroscience, and ophthalmology reshaping global pharma.
Pfizer CEO: All-in on Weight Loss Drug DevelopmentPfizerPfizer CEO Albert Bourla focuses on advancing weight loss drug development, with new small molecule GLP-1 treatments and cancer therapies. The company aims to tackle challenges in a rapidly growing market.